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Abstract 62 
Introduction: Female sex workers (FSW) in sub-Saharan Africa have a higher prevalence of HIV 63 
than other women of reproductive age.  Social, legal, and structural barriers influence their 64 
access to care.  Little is known about the HIV diagnosis and care cascade in most countries in 65 
southern Africa.  We aimed to describe the HIV diagnosis and care cascade among FSW in 66 
Zimbabwe. 67 
Methods: We conducted cross-sectional respondent driven sampling (RDS) surveys of FSW in 68 
14 sites across Zimbabwe as the baseline for a cluster-randomised controlled trial investigating 69 
a combination HIV prevention and care package. We administered a questionnaire, tested 70 
women for HIV and measured viral load. We report the mean, minimum and maximum RDS-2 71 
weighted site values.  72 
Results: The survey included 2,722 women, approximately 200 per site. The mean HIV 73 
prevalence was 57.5% (42.8-79.2 site minimum and maximum). Of HIV positive women, 64.0% 74 
(51.6-73.7) were aware of their status, 67.7% (53.4-84.1) of these reported taking ART and 75 
77.8% (64.4-90.8) of these had HIV viral load <1000 copies/ml. Among all HIV positive women, 76 
49.5% had a viral load < 1000 copies/ml.    77 
Conclusions: While the majority of HIV positive women aware of their status are accessing 78 
ART, 36.0% of HIV positive women are unaware of their status and 29.3% of all FSW have an 79 
unsuppressed HIV viral load. Investigation and investment into models of testing, treatment 80 
and care are necessary to reach UNAIDS 90:90:90 targets.  81 
 82 
The trial is registered with the Pan African Clinical Trials Registry (PACTR201312000722390).83 
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Introduction 122 
In sub-Saharan Africa, female sex workers (FSW) have high HIV incidence and prevalence and 123 
therefore are in particular need of good access to effective HIV testing, prevention and 124 
treatment services[1]. However, FSW are a marginalised group, sex work is illegal in many 125 
countries including Zimbabwe[2], and FSW are often stigmatised by communities and health 126 
workers[3, 4]. Typically, FSW are also highly mobile[5]. Designing service delivery approaches 127 
that meet the needs of this population is therefore complex but urgently needed.  128 
There is currently little information about the HIV diagnosis and care cascade amongst FSW 129 
with which to guide programming. Previous studies of FSW in sub-Saharan Africa indicate that 130 
antiretroviral therapy (ART) can be provided to FSW[6] at costs comparable to that of provision 131 
in the general population[7]. A recent systematic review and meta-analysis of antiretroviral 132 
uptake, adherence and outcomes among FSW found that current ART use among HIV positive 133 
FSW was 39% (95% CI 29-48%), but noted a concerning lack of published data available[8]. 134 
Another review of the provision of sexual and reproductive health services for FSW in Africa 135 
found little emphasis among programmes on access to antiretroviral treatment and support 136 
for adherence[9].  While there is some evidence to guide the design of HIV prevention 137 
programmes for FSW in Africa, little is known about the best means to improve testing, access 138 
and adherence to ART and effective use of pre-exposure prophylaxis[10, 11].  139 
In 2009, in response to a situational analysis conducted among FSW by Zimbabwe’s National 140 
AIDS Council and partners[12], the ‘Sisters with a Voice’ programme was established in five 141 
sites, and has since expanded to 36 sites covering all the provinces of Zimbabwe.  Services 142 
provided are based on guidance from the World Health Organisation[13] and include HIV 143 
testing and counselling, sexual and reproductive health services, condom provision and health 144 
education supported by trained peer educators and a programme of community mobilisation. 145 
Results of a respondent driven sampling (RDS) survey conducted in three towns in 2011[14], 146 
along with qualitative work[15], suggested that FSW in Zimbabwe were poorly engaged with 147 
HIV prevention and care services. 148 
In response to this finding, we launched the Sisters Antiretroviral Programme for Prevention of 149 
HIV – an Integrated Response (SAPPH-IRe) trial, a cluster-randomised controlled trial 150 
conducted in 14 sites around Zimbabwe (7 matched-pairs). The aim is to determine the 151 
effectiveness and cost effectiveness of an enhanced community-based intervention to increase 152 
uptake, retention and adherence to antiretroviral-based prevention and therapy among FSW. 153 
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Outcomes were assessed at a population level in all 14 communities among FSW recruited to 154 
RDS surveys at baseline (December 2013), and will also be assessed at endline (April-May 155 
2016).  156 
Aiming to contribute to our scant knowledge of the HIV diagnosis and care cascade amongst 157 
FSW in sub-Saharan Africa, this paper describes the HIV diagnosis and care cascade at 14 sites 158 
around Zimbabwe at the baseline of the SAPPH-IRe trial. Data are presented on socio-159 
demographic characteristics, HIV prevalence, ART coverage, viral suppression and the 160 
proportion of all FSW with unsuppressed HIV viral load: the primary endpoint for the SAPPH-161 
IRe trial.  162 
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Methods 163 
Study Population and Setting 164 
Fourteen of the 36 sites where the ‘Sisters’ services are provided are included in the SAPPH-165 
IRe trial. These sites were purposively selected to reflect different sex work location types (e.g. 166 
town, growth point, colliery/army base), were locations of adequate size (85-300 FSW 167 
attending clinics annually) and were geographically disparate to minimise contamination 168 
during the trial.  169 
Data Collection 170 
We conducted respondent driven sampling (RDS)[16] surveys of FSW using identical 171 
procedures in each of the 14 sites.   We used RDS because it was unfeasible to assemble a 172 
sampling frame of the intended target population; it has been recommended for research 173 
amongst hard-to-reach populations[17]; we successfully conducted similar RDS surveys of FSW 174 
in 3 locations in 2011[14], and sex work in these settings is not conducted primarily within 175 
brothels or set venues making time-location sampling methods less appropriate.  Women were 176 
eligible if they were aged 18 or over; had exchanged in sex for money or gifts in the preceding 177 
30 days, and had lived at the site for at least the previous six months.  In each site we first 178 
conducted 2-3 days of geographic and social mapping, including informal discussions with 179 
trained peer educators, healthcare staff, and community informants. This formative work 180 
informed specific criteria for purposely selected “seed” women to ensure that all sub-181 
populations within the site’s sex worker population were represented and helped determine 182 
how many of these seeds should be selected[18].  183 
In line with RDS methodology, seed participants in each site were interviewed and given two 184 
recruitment coupons to pass on to their sex worker peers. Women were uniformly advised to 185 
recruit other sex workers whose name they knew and who knew their name, who had not 186 
already enrolled in the study and who met the study eligibility criteria. Interviewers used 187 
screening questions to confirm as far as possible that women given coupons met these criteria 188 
when they presented for interview. Six seeds were recruited in the smaller sites, while in four 189 
larger sites eight seeds were recruited. When women receiving the coupons attended for the 190 
interview (“recruits”) they were also given two coupons to give out to women they knew who 191 
worked as FSW in that location. Coupons were coded such that recruiter/recruitee 192 
relationships could be tracked and unique IDs recorded. In all 14 sites a maximum of five 193 
iterations, or ‘waves’, of this process were performed (6 waves, including the initial seeds). We 194 
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aimed to recruit 200 FSW per site to give adequate power to detect the intervention effect at 195 
follow-up[19]. In line with other RDS surveys, women were reimbursed for participating in the 196 
survey ($5) and for recruiting eligible participants ($2 for each recruited). All participants gave 197 
informed consent to participate after receiving information about the study from trained 198 
interviewers and being given the opportunity to ask questions.  199 
Five teams of trained researchers undertook data collection between 13 November and 20 200 
December 2013. Interviewer-administered questionnaire data was collected onto tablet 201 
computers and directly loaded into a master database using a wireless internet connection in 202 
the field. Questionnaires included information on demographics, sex work, sexual behaviour 203 
and condom use, HIV testing history, ART use, stigma, experience of violence, relationships 204 
with other sex workers, and use of sexual and reproductive health services. We also collected 205 
data to determine personal network size, or ‘degree’, for RDS estimation. In our survey, the 206 
degree was the number of FSW a participant reported knowing personally, whose name they 207 
knew and who knew theirs, who were at least 18 years old, lived at the site, and whom the 208 
participant would consider recruiting to the study.  209 
All women had a finger prick blood sample collected in the form of a dried blood spot (DBS) for 210 
detection of HIV antibody (AniLabsytems EIA kit (AniLabsystems Ltd, OyToilette 3, FIN-01720, 211 
Finland)). Blood samples were air-dried on filter papers and stored at room temperature, then 212 
transported biweekly to the Flowcytometry Laboratory in Harare. If HIV antibodies were 213 
detected then the DBS sample was tested for HIV viral load using NucliSENS EasyQ HIV-1 v2.0, 214 
both to confirm HIV positive status and to quantify the viral load. For samples with a positive 215 
HIV antibody test, but an undetectable viral load, a second confirmatory ELISA was performed 216 
(Enzygnost Anti-HIV 1/2 Plus ELISA (Germany)). At two trial sites, plasma samples were 217 
collected in addition to DBS and tested in parallel using NucliSENS EasyQ HIV-1 v2.0, to permit 218 
validation of the use of DBS for viral load quantification [20].  219 
The Medical Research Council Zimbabwe, University College London, and the London School of 220 
Hygiene and Tropical Medicine gave ethical approval for the SAPPH-IRe trial, including the 221 
baseline data collection and analysis. The trial was also registered with the Research Council of 222 
Zimbabwe, the Pan African Clinical Trials Registry (PACTR201312000722390) and was 223 
approved by the Medicines Control Authority of Zimbabwe. 224 
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Data analysis 225 
We follow the recommendations of the STROBE-RDS guidelines in reporting our study[21]. 226 
First, we described the sample recruited. A limitation of RDS is that it is difficult to describe 227 
non-participation rates since no sample frame is present, and we did not conduct ‘exit 228 
interviews’ of women who had distributed coupons to ascertain how many of their peers 229 
refused to take part. We calculated cluster-summaries for key socio-demographic 230 
characteristics of the sample. We calculated and report the mean of the 14 cluster-level RDS-2 231 
weighted summaries and the range of estimates across clusters (minimum and maximum). 232 
Both as a total and summarised across clusters, we described the proportion of participants 233 
with suppressed HIV viral load, (<1000 copies/ml, as per WHO guidelines[22, 23]), and steps of 234 
the HIV care cascade underlying this: the proportion who were found to be HIV positive; the 235 
proportion who reported via questionnaire previously testing positive (i.e. knew their status); 236 
the proportion who reported being on ART, and the proportion who had a viral load of <1000 237 
copies/ml. We described these estimates both as proportions of the previous step on the 238 
cascade and as proportions of the total of women testing HIV positive.  239 
We used  ‘RDS-2’ to conduct all analyses, which uses the ‘Volz-Heckathorn’ estimator[24] and 240 
has been found to be less biased than previous estimators[25]. RDS-2 is based on estimating 241 
the inclusion probabilities of each survey participant, assuming the recruitment process can be 242 
modelled as a ‘random walk’ over the social network of FSW. Within this model, the 243 
probability that each participant will be included is approximated as the inverse of the 244 
reported degree. Estimates were calculated in Stata 12 using the ‘rds’ analysis package[26], 245 
which removes seeds from the proportion estimates.  246 
RDS-2 estimation assumes that recruitment chains progress such that final estimates are no 247 
longer dependent on the characteristics of the seeds, that recruitment does not become 248 
confined within sub-groups of the FSW population (‘bottlenecks’), and assumes with-249 
replacement sampling even when women cannot participate more than once in practice[25]. 250 
We assessed these assumptions and their potential for bias on estimates of HIV prevalence 251 
and suppressed viral load for each site, using plots of the convergence of HIV and viral 252 
suppression estimates over sample waves (‘convergence plots’) and plots of estimate 253 
convergence by seed (‘bottleneck plots’). We also examined the difference between RDS-2 254 
estimates and estimates produced using the RDS ‘successive sampling’ estimator[27] for a 255 
range of possible population sizes to assess the bias resulting from assuming with-replacement 256 
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sampling. These analyses were guided by published advice about RDS diagnostics[28] and used 257 
the ‘rds’ package for the R statistical language[29]. Details of the diagnostic methods and 258 
results are given in Appendix 1.  259 
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Results 260 
RDS recruitment and estimation 261 
In total 2,722 participants were recruited over six waves in 14 sites. Of these participants, 90 262 
were seeds, of whom 62 (68.9%) were HIV positive and 29 (32.2%) had HIV viral load ≥ 1000 263 
copies/ml. The number of non-seed “recruits” varied from 147 to 212 per site. There were an 264 
additional 15 participants from 8 sites who were missing recruiter information and who were 265 
treated as seeds and therefore dropped from the estimation.  266 
Estimates for the proportion of FSW with suppressed viral load and for HIV prevalence 267 
appeared to converge well by the final sample wave for all sites except one for HIV prevalence 268 
and two for viral load, and there was little evidence of recruitment becoming confined within 269 
sub-groups from any site (see Appendix 1). 270 
Characteristics of female sex workers  271 
Participants were aged between 18 and 65, with a mean age of 31 years (minimum site mean 272 
of 29 and maximum of 34). Approximately one third of women had no or only primary 273 
education, another third had completed Forms 1-3 and the final third had completed at least 274 
Form 4 (see Table 1). Very few of the women were married (0.8% overall unweighted, the 275 
proportion was too small to calculate RDS weights) and 61.9% (range 46.4-70.6% across sites) 276 
were separated or divorced. The majority of women (53.5%) reported initiating sex work by 24 277 
years old, with 17.4% (8.5 – 25.9) reporting having started sex work before they were 18 years 278 
old. In total 8.2% reported having no clients in the past week, 49.9% of women reported 279 
having between 1 and 5 clients per week; and 13.2% reported having 16 or more. Just under 280 
half of the women in each cluster (45.0%) were food insecure (food insecurity was indicated by 281 
any of the following: being unable to eat two meals a day; sometimes going to bed hungry; 282 
going an entire day without eating in the last week). More than a quarter of women (26.7%) 283 
had worked at another geographic location in the previous 12 months, while 52.2% had lived 284 
in their current location for six or more years. 61.4% of the women reported good or very good 285 
relations with other FSW.  286 
Violence from intimate partners was the most common form of interpersonal violence ever 287 
experienced (40.3%), followed by violence from clients (27.7%). Violence from police in the 288 
previous year was 9.7% overall, though in one location it was 19.5%.  289 
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290 
The majority of participants reported having previously tested for HIV (91.1%), and of those 291 
who were HIV negative 70.5% (52.7-88.8) reported having tested for HIV in the previous six 292 
months. 293 
HIV and the diagnosis and care cascade 294 
The HIV care cascade for HIV positive FSW is described in Figure 1. HIV prevalence amongst 295 
FSW was estimated to be 57.5%, ranging from 42.8% to 79.2% across sites. 296 
Among those who tested HIV positive, an average of 64.0% (51.6 – 73.7) in each site were 297 
aware of their status, i.e. they reported a previous positive HIV test. Of those aware of their 298 
positive status, 67.7% (53.4 – 84.1) reported taking ART, which was 43.3% (32.3 – 54.0) of all 299 
those who tested HIV positive in the study. Across sites, an average of 77.8% (64.4 – 90.8) of 300 
women who were on ART had a viral load < 1000 copies/ml. Women on ART with viral loads 301 
<1000 copies/mL were 33.7% (range 36.5 – 62.2) of all those testing HIV positive. An additional 302 
15.8% (range 12.6 – 16.6) of those testing positive had a viral load <1,000 copies/ml, despite 303 
not reporting being on ART. Of all HIV positive FSW, 43.3% (32.3 – 54.0) were on ART and 304 
49.5% (36.5-62.2) had viral loads of <1000 copies/mL.  305 
When considering all FSW as the denominator, there were an estimated 29.3% (18.9-42.3) of 306 
women who had an unsuppressed HIV viral load of ≥1000 copies/mL.307 
 308 
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Discussion 309 
We analysed data from 2,722 FSW recruited in 14 sites in Zimbabwe. HIV prevalence was very 310 
high (mean 57.5% across sites, ranging 42.8-79.2%). While recent HIV testing and access to 311 
ART were relatively common, still some 36.0% of HIV positive FSW did not report that they 312 
were positive in the research interview (26.3-48.4). The majority of women who tested HIV 313 
positive and reported being aware of their status reported accessing ART (67.7%) and of those, 314 
77.8% had a viral load <1000 copies/ml. However, overall only 49.5% of all HIV positive women 315 
had a viral load <1000 copies/ml, in part because many were unaware of their status. 316 
Significant and rapid progress is needed to reduce HIV infection rates, increase HIV status 317 
awareness and improve overall levels of viral suppression.  318 
We undertook an ambitious field study to collect baseline data and test the feasibility of our 319 
proposed approach to the trial endline data collection. We have shown that it was feasible to 320 
rapidly recruit approximately 200 FSW per site in 14 sites across Zimbabwe using RDS 321 
methodology. Our findings make an important contribution to the sparse literature on the HIV 322 
diagnosis and care cascade among FSW in sub-Saharan Africa[8]. We have been able to 323 
measure women having unsuppressed viral load as a proportion of all HIV positive sex 324 
workers, not only among those accessing ART, which is important given that approximately 325 
one third of HIV positive FSW were unaware of their status.  Sampling approaches such as ours 326 
provide a key means for assessing how close we are to the 90:90:90 targets[30] in a given 327 
population or setting.  328 
All sampling methods for hard-to-reach populations have limitations, and RDS is no exception. 329 
The estimation makes many assumptions about the recruitment process and the social 330 
networks of sex workers. Appropriate statistical techniques should be used though there 331 
remains debate about methods of analysis. We present diagnostics in Appendix 1. However, as 332 
in all applications of RDS in hidden populations it was not possible for us to empirically verify 333 
the extent to which the sample we recruited reflects the characteristics of FSWs working in the 334 
14 sites. A major strength of our study was that we adopted identical field procedures in each 335 
of the sites, strengthening our capacity to compare findings across them. 336 
Our estimate of viral load for HIV positive FSW was based on analysis of dried blood spot 337 
samples. While plasma analysis is normally considered the gold-standard approach, DBS 338 
appeared to be an acceptable method for viral load monitoring using the NucliSENS assay, and 339 
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we estimated high DBS sensitivity compared to plasma ‘gold-standard’ (sensitivity=87.4% and 340 
specificity=96.8%)[20].  341 
Coverage of ART among HIV positive FSW was similar at 43.4% (range 32.3 – 54.0) to the 40% 342 
we had hypothesised prior to the trial[19]. This was slightly higher but in the range of the 343 
pooled estimate of 39.3% (27.2-52.9%) among sex workers from low and middle income in 344 
studies found in a recent meta-analysis and systematic review[8]. Some 67.7% of those FSW 345 
who were aware of their status and reported they were positive also reported taking ART 346 
(range 53.4-84.1%). This was similar to our findings in three sites in 2011, when we found 51-347 
74% HIV positive FSWs who were aware of their HIV status were also engaged with care[14]. 348 
However, coverage is well below the 90:90:90 target set by UNAIDS[30]. Coverage among the 349 
general population of adult women in Zimbabwe is not known.  350 
Overall 77.8% of those reporting taking ART had a viral load <1000 copies/ml, as did 15.8% of 351 
HIV positive women who did not report being on ART. That such a large proportion of women 352 
not on ART had a suppressed viral load was not anticipated; one explanation is that women 353 
under-reported their knowledge of HIV status and ART usage. However, there have been other 354 
surveys with similar findings: the 2012 Kenya AIDS Indicator Survey found that 30% of 355 
individuals who reported not being on ART were virally suppressed[31] and among men who 356 
have sex with men in the United States reporting to be unaware of their status and therefore 357 
not on ART in 2004-2011, 2/11 to 3/7 were found to be virally suppressed[32]. We plan to 358 
investigate this further.   359 
Conclusions 360 
In conclusion, our findings have contributed to knowledge of the HIV care cascade among sex 361 
workers in southern Africa. They confirm the urgent need for HIV prevention and care services 362 
in this population. We hope that the SAPPH-Ire trial will contribute to our understanding of 363 
how best to serve the needs of female sex workers in the region.   364 
 365 
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Figure legend 455 
Figure 1: The y-axis indicates the proportion of women at each step of the cascade of all 456 
women testing HIV positive, while the figures on each bar indicate the proportion of women 457 
from each preceding step. Bars indicate the mean RDS weighted values across sites, while the 458 
coloured points are individual site values. The shaded portion of the virally suppressed bar 459 
represents those women who had a suppressed viral load, but who did not report taking ART. 460 
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Supplemental Digital Content  462 
Additional File 1, Appendix 1. RDS Diagnostics.  This is a MS Word “.docx” file that describes 463 
and reports on recommended diagnostic procedures carried out to test assumptions made by 464 
the Respondent Driven Sampling (RDS) method.  465 
